Press Releases

March 29, 2017

Warp Drive Bio Forms Technology Alliance with GSK to Discover Potential Therapeutics in Oncology and Other Diseases

Collaboration Combines Warp Drive’s SMART™ Technology with GSK’s ELT Platform to Design One-of-a-Kind Chemical Library

Read the Press Release

November 29, 2016

Warp Drive Bio Achieves Key Milestone in Antibiotics Collaboration with Sanofi

Read the Press Release

October 17, 2016

Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors

Read the Press Release

August 30, 2016

Warp Drive Bio Awarded Patent Covering Proprietary Method for Discovering New Medicines

New issuance is first to cover company’s proprietary SMART Platform

Read the Press Release

July 5, 2016

Warp Drive Bio Appoints Rachel K. King to its Board of Directors

Read the Press Release

April 6, 2016

Warp Drive Bio Appoints Alan C. Rigby, Ph.D., as Chief Scientific Officer

Addition of Key Hire Supports Vision of Building World-Class Research Team

Read the Press Release

January 11, 2016

Sanofi and Warp Drive Bio to Collaborate on the Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms

New Collaboration to Provide Warp Drive Bio Funding and Milestones in Excess of $750 Million

Read the Press Release

November 9, 2015

Warp Drive Bio Announces Formation of Board of World-Leading Oncology Experts to Focus on Company's RAS Program

Read the Press Release

November 9, 2015

Warp Drive Bio Announces Breakthrough in the Ability to Target the Previously Undruggable Oncogene RAS

New Drug Modality Will Be Deployed Broadly Against Undruggable Targets – Initial Program Targets Multiple Forms of RAS

Read the Press Release

November 2, 2015

Warp Drive Bio to Present First Program Using Small Molecule Assisted Receptor Targeting (SMART™) Platform Against the RAS Oncogene

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Read the Press Release

March 4, 2015

Warp Drive Bio Appoints Industry Veteran Laurence Reid, Ph.D., to Chief Executive Officer

Gregory Verdine, Ph.D., to Serve as President and Chief Scientific Officer

Read the Press Release

July 2, 2013

Warp Drive Bio Appoints Co-Founder Gregory Verdine, Ph.D., to Chief Executive Officer; Expands Team with Two Key Appointments

James Nichols, Ph.D., Appointed to Chief Operating Officer; Julian Adams, Ph.D., Joins Board of Directors

Read the Press Release

January 10, 2012

Third Rock Ventures and Sanofi Announce Launch of Warp Drive Bio; Broad Strategic Partnership Builds Innovative Genomics Search Engine to Reveal Nature's Drugs

Breakthrough Business Model Provides Initial Financing of $125 Million, Fosters Collaboration and Creates Independent, Innovative Biotech Compan

Read the Press Release